Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Triple Negative Breast Neoplasms
×
niraparib
×
Clear all
Filters
3
NCT04915755
2025-07-16
ZEST
GlaxoSmithKline
Phase 3
Active not recruiting
40 enrolled
13 charts
NCT02657889
2022-12-01
TOPACIO
Tesaro, Inc.
Phase 1/2
Completed
122 enrolled
29 charts